Metraipolis › archive › dc_dbb2003dcb5d

Multi-Target Drug Design in Alzheimer's Disease Treatment: Emerging Technologies, Advantages, Challenges, and Limitations — Europe PMC PMID:40531439

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/40531439
DOI: 10.1002/prp2.70131
License (as archived): solo-consultazione
Archived: 2026-10-08T02:36:29.395Z
SHA-256 of the archived text: 8156b8a15b01809979ce7e06f0f209c2603b751f7925a23be0d5cc1e14b1c5ce
Stable URL of this page: https://metraipolis.com/documento/dc_dbb2003dcb5d

How to cite

Multi-Target Drug Design in Alzheimer's Disease Treatment: Emerging Technologies, Advantages, Challenges, and Limitations — Europe PMC PMID:40531439 — Europe PMC (en), https://europepmc.org/article/MED/40531439 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_dbb2003dcb5d (Metraipolis archive dc_dbb2003dcb5d, sha256 8156b8a15b01809979ce7e06f0f209c2603b751f7925a23be0d5cc1e14b1c5ce)

BibTeX

@misc{dcdbb2003dcb5d,
  title = {Multi-Target Drug Design in Alzheimer's Disease Treatment: Emerging Technologies, Advantages, Challenges, and Limitations — Europe PMC PMID:40531439},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40531439},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_dbb2003dcb5d; sha256 8156b8a15b01809979ce7e06f0f209c2603b751f7925a23be0d5cc1e14b1c5ce},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40531439. Agents can read the archived copy with the MCP tool read_document.